Skip to main content

Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection

Buy Article:

$51.00 plus tax (Refund Policy)



Aim: A discrimination analysis has been explored for the probabilistic classification of healthy versus ovarian cancer serum samples using proteomics data from mass spectrometry (MS). Methods: The method employs data normalization, clustering, and a linear discriminant analysis on surface-enhanced laser desorption ionization (SELDI) time-of-flight MS data. The probabilistic classification method computes the optimal linear discriminant using the complex human blood serum SELDI spectra. Cross-validation and training/testing data-split experiments are conducted to verify the optimal discriminant and demonstrate the accuracy and robustness of the method. Results: The cluster discrimination method achieves excellent performance. The sensitivity, specificity, and positive predictive values are above 97% on ovarian cancer. The protein fraction peaks, which significantly contribute to the classification, can be available from the analysis process. Conclusion: The discrimination analysis helps the molecular identities of differentially expressed proteins and peptides between the healthy and ovarian patients.

Keywords: discrimination analysis; mass spectrometry; ovarian cancer; proteomics

Document Type: Research Article


Affiliations: 1: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China 2: Alps Biostatistics Services LLC, Philadelphia, Pennsylvania, USA

Publication date: 2008-10-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more